FIVE BELOW (FIVE)

US33829M1018 - Common Stock

144.81  +1.34 (+0.93%)

After market: 144.81 0 (0%)

Fundamental Rating

6

Overall FIVE gets a fundamental rating of 6 out of 10. We evaluated FIVE against 126 industry peers in the Specialty Retail industry. FIVE is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. FIVE is valued quite expensive, but it does show an excellent growth. These ratings would make FIVE suitable for growth investing!



6

1. Profitability

1.1 Basic Checks

FIVE had positive earnings in the past year.
In the past year FIVE had a positive cash flow from operations.
Each year in the past 5 years FIVE has been profitable.
In the past 5 years FIVE always reported a positive cash flow from operatings.

1.2 Ratios

FIVE has a Return On Assets of 7.78%. This is in the better half of the industry: FIVE outperforms 75.40% of its industry peers.
With a decent Return On Equity value of 19.00%, FIVE is doing good in the industry, outperforming 75.40% of the companies in the same industry.
FIVE has a Return On Invested Capital of 9.18%. This is in the better half of the industry: FIVE outperforms 67.46% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for FIVE is below the industry average of 13.97%.
Industry RankSector Rank
ROA 7.78%
ROE 19%
ROIC 9.18%
ROA(3y)8.44%
ROA(5y)7.92%
ROE(3y)21.03%
ROE(5y)20.02%
ROIC(3y)11.55%
ROIC(5y)10.28%

1.3 Margins

FIVE has a better Profit Margin (8.46%) than 87.30% of its industry peers.
FIVE's Profit Margin has declined in the last couple of years.
With an excellent Operating Margin value of 10.83%, FIVE belongs to the best of the industry, outperforming 84.92% of the companies in the same industry.
FIVE's Operating Margin has declined in the last couple of years.
FIVE has a Gross Margin of 35.79%. This is comparable to the rest of the industry: FIVE outperforms 49.21% of its industry peers.
In the last couple of years the Gross Margin of FIVE has remained more or less at the same level.
Industry RankSector Rank
OM 10.83%
PM (TTM) 8.46%
GM 35.79%
OM growth 3Y8.83%
OM growth 5Y-2.03%
PM growth 3Y10.39%
PM growth 5Y-2.48%
GM growth 3Y2.49%
GM growth 5Y-0.25%

8

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), FIVE is creating some value.
FIVE has less shares outstanding than it did 1 year ago.
The number of shares outstanding for FIVE has been reduced compared to 5 years ago.
FIVE has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

FIVE has an Altman-Z score of 3.98. This indicates that FIVE is financially healthy and has little risk of bankruptcy at the moment.
FIVE has a Altman-Z score of 3.98. This is amongst the best in the industry. FIVE outperforms 80.16% of its industry peers.
FIVE has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 3.98
ROIC/WACC1
WACC9.22%

2.3 Liquidity

FIVE has a Current Ratio of 1.68. This is a normal value and indicates that FIVE is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of FIVE (1.68) is better than 61.90% of its industry peers.
FIVE has a Quick Ratio of 1.68. This is a bad value and indicates that FIVE is not financially healthy enough and could expect problems in meeting its short term obligations.
FIVE's Quick ratio of 0.86 is fine compared to the rest of the industry. FIVE outperforms 62.70% of its industry peers.
Industry RankSector Rank
Current Ratio 1.68
Quick Ratio 0.86

7

3. Growth

3.1 Past

FIVE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 15.57%, which is quite good.
Measured over the past years, FIVE shows a quite strong growth in Earnings Per Share. The EPS has been growing by 15.56% on average per year.
FIVE shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 15.70%.
The Revenue has been growing by 17.94% on average over the past years. This is quite good.
EPS 1Y (TTM)15.57%
EPS 3Y35.47%
EPS 5Y15.56%
EPS growth Q2Q18.89%
Revenue 1Y (TTM)15.7%
Revenue growth 3Y21.96%
Revenue growth 5Y17.94%
Revenue growth Q2Q19.14%

3.2 Future

The Earnings Per Share is expected to grow by 25.19% on average over the next years. This is a very strong growth
FIVE is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 16.34% yearly.
EPS Next Y14.23%
EPS Next 2Y16.36%
EPS Next 3Y17.55%
EPS Next 5Y25.19%
Revenue Next Year13.32%
Revenue Next 2Y14.59%
Revenue Next 3Y15.18%
Revenue Next 5Y16.34%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.

3

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 26.72, the valuation of FIVE can be described as expensive.
Compared to the rest of the industry, the Price/Earnings ratio of FIVE is on the same level as its industry peers.
FIVE's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 28.28.
A Price/Forward Earnings ratio of 23.39 indicates a rather expensive valuation of FIVE.
FIVE's Price/Forward Earnings is on the same level as the industry average.
FIVE's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 20.88.
Industry RankSector Rank
PE 26.72
Fwd PE 23.39

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of FIVE is on the same level as its industry peers.
FIVE's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 48.61
EV/EBITDA 13.92

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates FIVE does not grow enough to justify the current Price/Earnings ratio.
The decent profitability rating of FIVE may justify a higher PE ratio.
FIVE's earnings are expected to grow with 17.55% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.88
PEG (5Y)1.72
EPS Next 2Y16.36%
EPS Next 3Y17.55%

0

5. Dividend

5.1 Amount

FIVE does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

FIVE BELOW

NASDAQ:FIVE (5/3/2024, 7:00:00 PM)

After market: 144.81 0 (0%)

144.81

+1.34 (+0.93%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap8.00B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 26.72
Fwd PE 23.39
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)1.88
PEG (5Y)1.72
Profitability
Industry RankSector Rank
ROA 7.78%
ROE 19%
ROCE
ROIC
ROICexc
ROICexgc
OM 10.83%
PM (TTM) 8.46%
GM 35.79%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.92
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.68
Quick Ratio 0.86
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)15.57%
EPS 3Y35.47%
EPS 5Y
EPS growth Q2Q
EPS Next Y14.23%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)15.7%
Revenue growth 3Y21.96%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y